Shire faces reverse-payment lawsuit over ADHD medication
An independent South Carolina pharmacy has filed a class action complaint against Shire for entering into an agreement with Actavis to allegedly keep a generic version of its brand-name attention deficit hyperactivity disorder medication off the market.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10